MUSELLA, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 3.641
AS - Asia 2.060
EU - Europa 695
SA - Sud America 227
Continente sconosciuto - Info sul continente non disponibili 194
AF - Africa 43
OC - Oceania 6
Totale 6.866
Nazione #
US - Stati Uniti d'America 3.319
CN - Cina 560
SG - Singapore 558
IT - Italia 484
TR - Turchia 480
CA - Canada 278
VN - Vietnam 171
BR - Brasile 169
HK - Hong Kong 72
DE - Germania 54
BD - Bangladesh 42
PK - Pakistan 41
EU - Europa 28
IL - Israele 28
IN - India 26
GB - Regno Unito 25
AR - Argentina 20
FI - Finlandia 18
MX - Messico 15
IQ - Iraq 14
RU - Federazione Russa 14
ES - Italia 13
ID - Indonesia 13
IE - Irlanda 13
NL - Olanda 13
SC - Seychelles 13
JP - Giappone 12
PL - Polonia 10
SE - Svezia 10
EC - Ecuador 9
FR - Francia 9
ZA - Sudafrica 9
CL - Cile 8
CR - Costa Rica 8
CO - Colombia 7
UA - Ucraina 7
VE - Venezuela 7
SA - Arabia Saudita 6
UZ - Uzbekistan 6
AU - Australia 5
CH - Svizzera 5
EG - Egitto 5
MA - Marocco 5
NP - Nepal 5
BO - Bolivia 4
JM - Giamaica 4
KR - Corea 4
PH - Filippine 4
IR - Iran 3
JO - Giordania 3
LT - Lituania 3
RO - Romania 3
TN - Tunisia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
BB - Barbados 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GT - Guatemala 2
HN - Honduras 2
KW - Kuwait 2
RS - Serbia 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AZ - Azerbaigian 1
BE - Belgio 1
BF - Burkina Faso 1
BG - Bulgaria 1
BM - Bermuda 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
DK - Danimarca 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
MD - Moldavia 1
ML - Mali 1
MR - Mauritania 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 6.702
Città #
Dallas 518
San Mateo 448
Kocaeli 401
San Jose 372
Ashburn 340
Rome 252
Toronto 230
Council Bluffs 205
Singapore 150
Beijing 146
Santa Clara 132
Wilmington 113
Phoenix 108
Houston 87
Princeton 85
Lawrence 78
Hong Kong 66
Ho Chi Minh City 63
Chandler 54
Los Angeles 46
Hanoi 42
Shanghai 42
Islamabad 36
Chicago 29
Netanya 25
Guangzhou 23
Frankfurt am Main 22
Seattle 21
New York 19
São Paulo 19
The Dalles 19
Fairfield 18
Columbus 16
Woodbridge 16
Brooklyn 15
Shenzhen 14
Milan 13
West Jordan 11
Boston 10
Montreal 10
Tokyo 10
Turku 10
Da Nang 9
Falls Church 9
Mexico City 9
Atlanta 8
Cambridge 8
Helsinki 8
London 8
Warsaw 8
Amsterdam 7
Chennai 7
Jiaxing 7
Las Vegas 7
San Francisco 7
San José 7
Florence 6
Johannesburg 6
Rui'an 6
Wuxi 6
Ankara 5
Boardman 5
Buffalo 5
Manchester 5
Naples 5
Philadelphia 5
Salvador 5
Stockholm 5
Tashkent 5
The Bronx 5
Viggiù 5
Xi'an 5
Berlin 4
Biên Hòa 4
Guayaquil 4
Haiphong 4
Hải Dương 4
Orem 4
Palermo 4
Pune 4
Quito 4
Recife 4
Redwood City 4
Seoul 4
Turin 4
Vancouver 4
Wuhan 4
Ahmedabad 3
Alessandria 3
Baghdad 3
Belo Horizonte 3
Bern 3
Caracas 3
Charlotte 3
Chengdu 3
Curitiba 3
Dongyang 3
Fayetteville 3
Jakarta 3
Jeddah 3
Totale 4.626
Nome #
4-Aminopyridine derivatives with anticholinesterase and antiamnesic activity 375
'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting 117
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis 116
Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis 104
GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis 95
A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum 94
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis 91
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis 88
Caffeine drinking potentiates cannabinoid transmission in the striatum: interaction with stress effects 86
Il-1β Dependent Cerebellar Synaptopathy in a Mouse Mode of Multiple Sclerosis 84
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 84
Before or after does it matter? Different protocols of environmental enrichment differently influence motor, synaptic and structural deficits of cerebellar origin 83
Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis 83
TNF-α-mediated anxiety in a mouse model of multiple sclerosis 82
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 82
Behavioral and electrophysiological effects of endocannabinoid and dopaminergic systems on salient stimuli 81
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA 81
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome 81
A Dynamic Splicing Program Ensures Proper Synaptic Connections in the Developing Cerebellum 78
Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis 77
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 77
Linking synaptopathy and gray matter damage in multiple sclerosis 76
Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis 76
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis. 76
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis 75
Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis 75
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis 74
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum 73
Adaptations of striatal endocannabinoid system during stress 73
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients 73
Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum 72
Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons 72
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 72
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 72
Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions 71
Interleukin-1β promotes long-term potentiation in patients with multiple sclerosis 71
Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis 71
Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis 70
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter 70
Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum 70
Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis 69
Obesity worsens central inflammation and disability in multiple sclerosis 69
Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination 69
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis 69
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis 68
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum 68
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 68
Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity 67
Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis 66
Adaptations of glutamatergic synapses in the striatum contribute to recovery from cerebellar damage 66
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis 66
Interleukin-1β causes anxiety by interacting with the endocannabinoid system 65
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 65
MiR-142-3p is a key regulator of IL-1β-dependent synaptopathy in neuroinflammation 64
The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission 63
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 63
Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis 62
TRPV1 channels facilitate glutamate transmission in the striatum 62
Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation 62
Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study 61
Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum 61
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis 61
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis 59
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 59
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis 59
Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis 59
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 58
Differences in spontaneously avoiding or approaching mice reflect differences in CB1-mediated signaling of dorsal striatal transmission 57
Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity 57
Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake 57
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 56
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis 55
Cerebellar control of cortico-striatal LTD 55
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis 55
Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis 54
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis 53
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis 53
Preventive exercise and physical rehabilitation promote long‐term potentiation‐like plasticity expression in patients with multiple sclerosis 53
Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis 52
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis 52
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis 52
Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum 52
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 52
Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum 51
Effects of caffeine on striatal neurotransmission: focus on cannabinoid CB1 receptors 51
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 50
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 49
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis 48
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis 48
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation 46
Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression 44
Electrophysiology of Endocannabinoid Signaling 44
Special Issue Title: The neuroimmune crosstalk in mood disturbances of neurological and psychiatric diseases 40
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 38
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis 38
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis 37
Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients 36
Interaction between miR-142-3p and BDNF Val/Met Polymorphism Regulates Multiple Sclerosis Severity 35
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 28
IL-1β contributes to neurological disability in NMOSD AQP4 + Patients 27
Totale 6.824
Categoria #
all - tutte 56.632
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.632


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022415 0 0 0 4 6 8 34 92 20 226 19 6
2022/2023306 179 4 4 19 8 14 0 9 10 19 23 17
2023/2024226 4 6 8 41 6 14 1 12 0 37 0 97
2024/20251.002 50 160 103 56 37 145 65 48 145 22 39 132
2025/20262.717 155 248 479 199 268 255 349 247 142 275 56 44
2026/2027909 21 295 361 232 0 0 0 0 0 0 0 0
Totale 6.866